(1) Epidemiologic, clinical, radiologic and serologic evidence suggests that psoriatic arthritis
is a specific entity and not the coincidental occurrence of two common diseases, psoriasis …

Psoriatic arthritis (PsA) affects up to one-third of patients with psoriasis. It is the major
comorbidity of psoriasis because of the likelihood that loss of function and permanent …

Objectives To compare efficacy and safety of ixekizumab (IXE) to adalimumab (ADA) in
biological disease-modifying antirheumatic drug-naïve patients with both active psoriatic …

Objectives To evaluate the effect of subcutaneous (sc) secukinumab, an interleukin-17A
inhibitor, on clinical signs and symptoms and radiographic progression in patients with …

BACKGROUND: Psoriatic arthritis (PsA) is associated with multiple comorbid conditions,
including cardiovascular (CV) comorbidities that impose a considerable burden on patients …

Psoriatic arthritis (PsA) is a systemic inflammatory condition characterised by multiple
clinical manifestations. Over the last decade, significant progress has been made in …

Background Contemporary data on rheumatoid arthritis (RA), psoriatic arthritis (PsA) and
axial spondyloarthritis (SpA) epidemiology in England are lacking. This knowledge is crucial …

Introduction The EULAR group recently published the definition of difficult-to-treat (D2T)
patients for rheumatoid arthritis. However, a similar definition is lacking for patients with …

Objective To assess the long-term (3 year) efficacy and safety of secukinumab in patients
with active psoriatic arthritis (PsA) in the extension phase of the FUTURE 1 study …

Dactylitis is diffuse swelling of the digits that is usually related to an underlying inflammatory
or infiltrative disorder. Psoriatic arthritis (PsA) is the most common severe disease thought to …